|
|
| 5-Day | 6,531 |
| 10-Day | 5,953 |
| 30-Day | 9,591 |
| 5-Day | 6,531 |
| 10-Day | 5,953 |
| 30-Day | 9,591 |
| 5-Day | 8,367 |
| 10-Day | 7,812 |
| 30-Day | 11,650 |
| 5-Day | 8,367 |
| 10-Day | 7,812 |
| 30-Day | 11,650 |
Announcements
Bal Pharma: Board meeting on April 16, 2014Announcements
Bal Pharma: Outcome of board meetingOnly Buyers
Only Buyers in Bal Pharma on NSE52 Week High
Bal Pharma has hit a 52wk high of Rs 41.60 on NSEOnly Buyers
Only Buyers in Bal Pharma on NSE52 Week High
Bal Pharma has hit a 52wk high of Rs 39.75 on NSEOnly Buyers
Only Buyers in Bal Pharma on NSE52 Week High
Bal Pharma has hit a 52wk high of Rs 37.90 on NSE52 Week High
Bal Pharma has hit a 52wk high of Rs 35.45 on BSE52 Week High
Bal Pharma has hit a 52wk high of Rs 35.20 on NSE52 Week High
Bal Pharma has hit a 52wk high of Rs 35.05 on NSE52 Week High
Bal Pharma has hit a 52wk high of Rs 32.20 on NSE52 Week High
Bal Pharma has hit a 52wk high of Rs 31.85 on NSEOnly Buyers
Only Buyers in Bal Pharma on NSE52 Week High
Bal Pharma has hit a 52wk high of Rs 30.45 on BSEOnly Buyers
Only Buyers in Bal Pharma on NSE
| Days | BSE | NSE |
| 30 | 33.80 | 33.62 |
| 50 | 31.82 | 31.97 |
| 150 | 24.60 | 24.38 |
| 200 | 22.38 | 0.00 |
Click here to view the Open, High, Low, Close, Volume and Spread data for Bal Pharma
| Standalone | (Dec '13) | (Sep '13) |
| Net Sales | 43.28 | 46.76 |
| Other Income | 0.05 | 0.15 |
| PBDIT | 4.59 | 4.65 |
| Net Profit | 1.39 | 1.41 |
| Total Share Capital | 10.57 |
| Net Worth | 44.62 |
| Total Debt | 46.03 |
| Net Block | 51.83 |
| Investments | 0.02 |
| Net Current Assets | 37.93 |
| Total Assets | 90.65 |
| Company Name | Last Price | % Change |
52 wk High |
52 wk Low |
Market Cap |
| Sun Pharma | 624.30 | 1.58 | 653.10 | 462.50 | 129,302.76 |
| Dr Reddys Labs | 2556.00 | 0.66 | 2939.80 | 1904.15 | 43,479.83 |
| Lupin | 955.25 | 0.23 | 1012.00 | 685.80 | 42,831.10 |
| Cipla | 400.60 | 0.96 | 450.00 | 375.00 | 32,165.03 |
| GlaxoSmithKline | 2497.40 | -0.43 | 3054.40 | 2225.00 | 21,153.73 |
| More » | |||||
| Mar' 14 | Dec' 13 | Sep' 13 | Jun' 13 | |
| Promoter | 53.72 | 51.37 | 51.37 | 51.37 |
| FII | 0.00 | 0.00 | 0.00 | 0.00 |
| DII | 0.02 | 0.02 | 0.02 | 0.02 |
| Others | 46.26 | 48.61 | 48.61 | 48.61 |
| Total | 100.00 | 100.00 | 100.00 | 100.00 |
| No Mutual Funds Holding the share |
Bal Pharma is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 36.78 crore.The company has reported a standalone sales of Rs 43.28 crore and a Net Profit of Rs 1.39 crore for the quarter ended Dec 2013.
The company management includes Shailesh Siroya - Managing Director, S Prasanna - Whole Time Director, Shrenik Siroya - Non Executive Director, G S R Subba Rao - Independent Director, S Pramod Kumar - Independent Director, Ajit Kumar - Nominee Director.
It is listed on the BSE with a BSE Code of 524824 and the NSE with an NSE Code of BALPHARMA.
Its Registered office is at 21 & 22, Bommasandra Industrial Area,,Hosur Road Bangalore,Karnataka - 560099.
Their Registrars are TSR Darashaw Ltd.
SET SMS ALERT
